Chongqing Precision Biotech Co., Ltd   Report issue

For profit Phase 1 Phase 2
Founded: Chongqing China (2016)

Organization Overview

First Clinical Trial
2019
NCT04271644
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chongqing Precision Biotech Co., Ltd | Precision Biotech Taiwan Corp.